Propel Bio Management, LLC Diversified Active

Name: Propel Bio Management, LLC Q2 2026 13F Filing | 13F Explorer
Creator: Propel Bio Management, LLC
Published: 2026-08-13

Location: Los Angeles, CA

CIK: 0001969764 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 13, 2026

Total Value: $191M (100.0% shares, 0.0% debt)

Holdings (29)

New Positions (4)

IMUX IMMUNIC INC 2.6%

Value $4.996M Shares 325,022 Est. Cost — Unrealized —

SCYX SCYNEXIS INC 1.2%

Value $2.212M Shares 543,478 Est. Cost — Unrealized —

SLN SILENCE THERAPEUTICS PLC 1.1%

Value $2.105M Shares 191,733 Est. Cost — Unrealized —

SGMT SAGIMET BIOSCIENCES INC-A 0.5%

Value $973K Shares 125,878 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
IMUX	IMMUNIC INC	325,022	$4.996M	2.6%	—	—	COMM	4525EP200
SCYX	SCYNEXIS INC	543,478	$2.212M	1.2%	—	—	COMM	811292309
SLN	SILENCE THERAPEUTICS PLC	191,733	$2.105M	1.1%	—	—	ADRS	82686Q101
SGMT	SAGIMET BIOSCIENCES INC-A	125,878	$973K	0.5%	—	—	COMM	786700104

Increased Positions (11)

ACHV ACHIEVE LIFE SCIENCES INC 13.8%

Value $26.34M (+131.7%) Shares 4,034,018 (+6.5%) Est. Cost — Unrealized —

ARTV ARTIVA BIOTHERAPEUTICS IN 3.5%

Value $6.755M (+611.2%) Shares 696,436 (+375.8%) Est. Cost — Unrealized —

MIST MILESTONE PHARMACEUTICALS 5.2%

Value $9.956M (+95.9%) Shares 7,429,590 (+80.4%) Est. Cost — Unrealized —

PALI PALISADE BIO INC 2.8%

Value $5.397M (+170.3%) Shares 2,582,388 (+131.6%) Est. Cost — Unrealized —

AQST AQUESTIVE THERAPEUTICS IN 3.1%

Value $6M (+103.4%) Shares 1,442,397 (+102.9%) Est. Cost — Unrealized —

KYTX KYVERNA THERAPEUTICS INC 4.1%

Value $7.869M (+40.9%) Shares 883,198 (+37.1%) Est. Cost — Unrealized —

PHAT PHATHOM PHARMACEUTICALS I 6.0%

Value $11.4M (+21.8%) Shares 1,050,358 (+24.9%) Est. Cost — Unrealized —

OVID OVID THERAPEUTICS INC 1.6%

Value $3.001M (+47.3%) Shares 1,115,538 (+21.1%) Est. Cost — Unrealized —

IVA INVENTIVA SA - ADR 2.5%

Value $4.843M (+21.2%) Shares 1,281,212 (+76.8%) Est. Cost — Unrealized —

UPB UPSTREAM BIO INC 1.3%

Value $2.425M (-21.8%) Shares 350,389 (+2.5%) Est. Cost — Unrealized —

SABS SAB BIOTHERAPEUTICS INC 2.2%

Value $4.199M (+8.0%) Shares 1,076,578 (+6.3%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACHV	ACHIEVE LIFE SCIENCES INC	4,034,018 (+6.5%)	$26.34M (+131.7%)	13.8%	—	—	COMM	004468500
ARTV	ARTIVA BIOTHERAPEUTICS IN	696,436 (+375.8%)	$6.755M (+611.2%)	3.5%	—	—	COMM	04317A107
MIST	MILESTONE PHARMACEUTICALS	7,429,590 (+80.4%)	$9.956M (+95.9%)	5.2%	—	—	COMM	59935V107
PALI	PALISADE BIO INC	2,582,388 (+131.6%)	$5.397M (+170.3%)	2.8%	—	—	COMM	696389402
AQST	AQUESTIVE THERAPEUTICS IN	1,442,397 (+102.9%)	$6M (+103.4%)	3.1%	—	—	COMM	03843E104
KYTX	KYVERNA THERAPEUTICS INC	883,198 (+37.1%)	$7.869M (+40.9%)	4.1%	—	—	COMM	501976104
PHAT	PHATHOM PHARMACEUTICALS I	1,050,358 (+24.9%)	$11.4M (+21.8%)	6.0%	—	—	COMM	71722W107
OVID	OVID THERAPEUTICS INC	1,115,538 (+21.1%)	$3.001M (+47.3%)	1.6%	—	—	COMM	690469101
IVA	INVENTIVA SA - ADR	1,281,212 (+76.8%)	$4.843M (+21.2%)	2.5%	—	—	COMM	46124U107
UPB	UPSTREAM BIO INC	350,389 (+2.5%)	$2.425M (-21.8%)	1.3%	—	—	COMM	91678A107
SABS	SAB BIOTHERAPEUTICS INC	1,076,578 (+6.3%)	$4.199M (+8.0%)	2.2%	—	—	COMM	78397T202

Exited Positions (13)

VOR VOR BIOPHARMA INC 2.9%

Value $5.587M Shares 314,543 Est. Cost — Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 2.1%

Value $4.088M Shares 210,163 Est. Cost — Unrealized —

OCS OCULIS HOLDING AG 1.7%

Value $3.279M Shares 122,223 Est. Cost — Unrealized —

TRVI TREVI THERAPEUTICS INC 1.4%

Value $2.647M Shares 223,802 Est. Cost — Unrealized —

IMUX IMMUNIC INC 1.4%

Value $2.62M Shares 2,344,779 Est. Cost — Unrealized —

CHRS COHERUS ONCOLOGY INC 1.3%

Value $2.413M Shares 1,420,550 Est. Cost — Unrealized —

KLRS KALARIS THERAPEUTICS INC 0.9%

Value $1.721M Shares 295,771 Est. Cost — Unrealized —

QURE UNIQURE NV 0.9%

Value $1.713M Shares 104,772 Est. Cost — Unrealized —

NUVB NUVATION BIO INC 0.7%

Value $1.413M Shares 329,296 Est. Cost — Unrealized —

EVMN EVOMMUNE INC 0.7%

Value $1.28M Shares 55,664 Est. Cost — Unrealized —

ALDX ALDEYRA THERAPEUTICS INC 0.6%

Value $1.235M Shares 730,606 Est. Cost — Unrealized —

CNTB CONNECT BIOPHARMA HLDGS LTD 0.3%

Value $554K Shares 209,493 Est. Cost — Unrealized —

MSLE SATELLOS BIOSCIENCE INC 0.0%

Value $57,116 Shares 10,145 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
VOR	VOR BIOPHARMA INC	314,543	$5.587M	2.9%	—	—	—	929033207
VRDN	VIRIDIAN THERAPEUTICS INC	210,163	$4.088M	2.1%	—	—	—	92790C104
OCS	OCULIS HOLDING AG	122,223	$3.279M	1.7%	—	—	—	H5870P102
TRVI	TREVI THERAPEUTICS INC	223,802	$2.647M	1.4%	—	—	—	89532M101
IMUX	IMMUNIC INC	2,344,779	$2.62M	1.4%	—	—	—	4525EP101
CHRS	COHERUS ONCOLOGY INC	1,420,550	$2.413M	1.3%	—	—	—	19249H103
KLRS	KALARIS THERAPEUTICS INC	295,771	$1.721M	0.9%	—	—	—	482929106
QURE	UNIQURE NV	104,772	$1.713M	0.9%	—	—	—	N90064101
NUVB	NUVATION BIO INC	329,296	$1.413M	0.7%	—	—	—	67080N101
EVMN	EVOMMUNE INC	55,664	$1.28M	0.7%	—	—	—	30054Y107
ALDX	ALDEYRA THERAPEUTICS INC	730,606	$1.235M	0.6%	—	—	—	01438T106
CNTB	CONNECT BIOPHARMA HLDGS LTD	209,493	$554K	0.3%	—	—	—	G23549101
MSLE	SATELLOS BIOSCIENCE INC	10,145	$57,116	0.0%	—	—	—	80401L803

Decreased Positions (10)

CORT CORCEPT THERAPEUTICS INC 6.2%

Value $11.87M (+97.1%) Shares 136,499 (-7.7%) Est. Cost — Unrealized —

CMPS COMPASS PATHWAYS PLC 4.2%

Value $8.109M (+96.9%) Shares 573,086 (-22.8%) Est. Cost — Unrealized —

DCTH DELCATH SYSTEMS INC 5.7%

Value $10.97M (+19.8%) Shares 871,460 (-11.0%) Est. Cost — Unrealized —

ZVRA ZEVRA THERAPEUTICS INC 1.9%

Value $3.636M (+37.7%) Shares 253,544 (-10.2%) Est. Cost — Unrealized —

OCUL OCULAR THERAPEUTIX INC 1.8%

Value $3.515M (+9.0%) Shares 357,966 (-6.4%) Est. Cost — Unrealized —

CLDX CELLDEX THERAPEUTICS INC 2.0%

Value $3.858M (-6.7%) Shares 103,695 (-21.1%) Est. Cost — Unrealized —

FDMT 4D MOLECULAR THERAPEUTICS IN 1.8%

Value $3.36M (-6.2%) Shares 252,654 (-33.6%) Est. Cost — Unrealized —

CRVS CORVUS PHARMACEUTICALS INC 0.6%

Value $1.051M (-16.0%) Shares 70,380 (-18.0%) Est. Cost — Unrealized —

ABEO ABEONA THERAPEUTICS INC 3.2%

Value $6.075M (+1.1%) Shares 983,070 (-26.1%) Est. Cost — Unrealized —

EYPT EYEPOINT INC 1.4%

Value $2.742M (-1.7%) Shares 191,745 (-11.2%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CORT	CORCEPT THERAPEUTICS INC	136,499 (-7.7%)	$11.87M (+97.1%)	6.2%	—	—	COMM	218352102
CMPS	COMPASS PATHWAYS PLC	573,086 (-22.8%)	$8.109M (+96.9%)	4.2%	—	—	ADRS	20451W101
DCTH	DELCATH SYSTEMS INC	871,460 (-11.0%)	$10.97M (+19.8%)	5.7%	—	—	COMM	24661P807
ZVRA	ZEVRA THERAPEUTICS INC	253,544 (-10.2%)	$3.636M (+37.7%)	1.9%	—	—	COMM	488445206
OCUL	OCULAR THERAPEUTIX INC	357,966 (-6.4%)	$3.515M (+9.0%)	1.8%	—	—	COMM	67576A100
CLDX	CELLDEX THERAPEUTICS INC	103,695 (-21.1%)	$3.858M (-6.7%)	2.0%	—	—	COMM	15117B202
FDMT	4D MOLECULAR THERAPEUTICS IN	252,654 (-33.6%)	$3.36M (-6.2%)	1.8%	—	—	COMM	35104E100
CRVS	CORVUS PHARMACEUTICALS INC	70,380 (-18.0%)	$1.051M (-16.0%)	0.6%	—	—	COMM	221015100
ABEO	ABEONA THERAPEUTICS INC	983,070 (-26.1%)	$6.075M (+1.1%)	3.2%	—	—	COMM	00289Y206
EYPT	EYEPOINT INC	191,745 (-11.2%)	$2.742M (-1.7%)	1.4%	—	—	COMM	30233G209

Unchanged Positions (4)

PAGP PLAINS GP HOLDINGS LP-CL 16.2%

Value $30.88M Shares 1,272,360 Est. Cost — Unrealized —

LONA LEONABIO INC 0.7%

Value $1.372M Shares 149,279 Est. Cost — Unrealized —

OBIO ORCHESTRA BIOMED HOLDINGS 2.0%

Value $3.869M Shares 896,701 Est. Cost — Unrealized —

MAZE MAZE THERAPEUTICS INC 0.7%

Value $1.307M Shares 43,798 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PAGP	PLAINS GP HOLDINGS LP-CL	1,272,360	$30.88M	16.2%	—	—	COMM	72651A207
LONA	LEONABIO INC	149,279	$1.372M	0.7%	—	—	COMM	04746L203
OBIO	ORCHESTRA BIOMED HOLDINGS	896,701	$3.869M	2.0%	—	—	COMM	68572M106
MAZE	MAZE THERAPEUTICS INC	43,798	$1.307M	0.7%	—	—	COMM	578784100